Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Jan, 8 2026

Many older adults take medications every day to manage pain, allergies, bladder issues, or depression. But what if some of those pills are quietly harming their memory and thinking? That’s the reality of anticholinergic burden - a hidden risk built into common prescriptions and even over-the-counter drugs. It’s not a disease. It’s not a rare side effect. It’s the slow, cumulative damage caused by drugs that block a key brain chemical called acetylcholine. And for seniors, that damage can show up as confusion, forgetfulness, or even faster progression toward dementia.

What Exactly Is Anticholinergic Burden?

Anticholinergic burden, or ACB, is the total amount of anticholinergic drugs a person is taking. These drugs stop acetylcholine from doing its job - sending signals between nerve cells. In the brain, acetylcholine helps with attention, memory, and learning. When it’s blocked, those functions slow down. It’s like turning down the volume on your brain’s most important conversations.

The problem isn’t one drug. It’s the sum of many. A person might take diphenhydramine (Benadryl) for sleep, oxybutynin for an overactive bladder, and amitriptyline for nerve pain. Each one carries a small risk. Together, they add up. That’s why doctors now use scoring systems like the ACB scale to measure the total burden. Each drug gets a rating: Level 1 (mild), Level 2 (moderate), or Level 3 (strong). A score of 3 or higher is considered high risk. A score of 6 or more? That’s a red flag.

Which Medications Carry the Highest Risk?

Not all anticholinergics are the same. Some cross into the brain easily. Others stay mostly in the body. The worst offenders are the ones that reach the brain and stay there.

  • First-generation antihistamines: Diphenhydramine (Benadryl), chlorpheniramine. These are in many sleep aids and cold medicines. They’re cheap, easy to get, and dangerously common.
  • Overactive bladder drugs: Oxybutynin, tolterodine. These help with frequent urination, but they also fog the mind. Many seniors don’t realize their confusion isn’t just aging - it’s the medication.
  • Tricyclic antidepressants: Amitriptyline, nortriptyline. These are older antidepressants. Newer ones like sertraline or escitalopram don’t have this effect.
  • Antipsychotics: Chlorpromazine, quetiapine. Used for behavioral issues in dementia, but they worsen cognition.
  • Pain meds: Some muscle relaxants like cyclobenzaprine.
In 2022, about 10% of adults over 65 in the U.S. were taking drugs with strong anticholinergic effects. That’s over 5 million people. And in many cases, these drugs were prescribed without anyone ever mentioning the brain risks.

How Do These Drugs Actually Damage the Brain?

It’s not just about feeling foggy. Brain scans show real, measurable changes.

A 2016 study in JAMA Neurology found that older adults taking even moderate levels of anticholinergic drugs had 4% less glucose use in the temporal lobe - the same area that shuts down early in Alzheimer’s disease. Less glucose means less energy for brain cells to work properly.

MRI scans from the Indiana Memory and Aging Study showed that people on high ACB medications lost brain volume 0.24% faster each year than those not taking them. That’s not just aging. That’s accelerated shrinkage.

And it’s not random. The brain regions hit hardest are the hippocampus (memory) and the prefrontal cortex (planning, focus). That’s why the biggest declines show up in two areas: episodic memory (forgetting names, appointments, recent conversations) and executive function (trouble making decisions, following instructions, switching tasks).

In the ASPREE study of nearly 20,000 seniors, each extra point on the ACB scale meant a 0.15-point greater yearly drop on tests of word fluency. That might sound small, but over three years, it adds up to a noticeable decline in daily function.

Geriatrician and older woman reviewing medications together in a cozy clinic, tablet showing ACB app.

How Long Does It Take to See the Damage?

It’s not overnight. But the longer you take these drugs, the worse it gets.

A landmark 2015 study found that people who took anticholinergic drugs for three years or more had a 54% higher risk of developing dementia than those who took them for less than three months. The risk climbed steadily with each year of use. Even people who never had memory problems before started showing signs.

And here’s the scary part: the damage doesn’t always reverse right away. In the DICE trial, seniors who stopped high-risk medications took 4 to 8 weeks just to start feeling clearer. Full cognitive recovery took 12 weeks or more. Some never fully bounced back.

What Do Experts Say?

The American Geriatrics Society’s 2023 Beers Criteria says: avoid strong anticholinergics in older adults. Period. The European Medicines Agency banned dimenhydrinate in dementia patients in 2020. The FDA now requires stronger warning labels on all these drugs.

Dr. Malaz Boustani, who helped create the ACB scale, calls this one of the few modifiable risk factors for dementia we actually have control over. That’s huge. We can’t stop aging. But we can stop taking drugs that make brain decline worse.

But not everyone agrees. Some doctors point out that people prescribed these drugs often have other health problems - depression, chronic pain, bladder issues - that might themselves raise dementia risk. That’s true. But even after adjusting for those factors, the link between anticholinergic burden and cognitive decline still shows up in study after study.

Real People, Real Stories

On forums like AgingCare.com, caregivers are sharing what happens when these drugs are stopped.

One woman wrote: “My mom was confused all the time. She forgot where she was, who we were. We thought it was dementia. Then her doctor switched her from oxybutynin to a different bladder med. Two weeks later, she remembered her grandchildren’s names. She started laughing again.”

The FDA recorded over 1,200 cognitive-related adverse events in seniors between 2018 and 2022. The most common? Confusion, memory loss, and sudden delirium. In a 2021 survey, 63% of older adults said they were never told about these risks when the drugs were prescribed. And 41% said they’d have chosen something else if they’d known.

Senior woman laughing with grandchildren, holding photo album, safer medications visible in cabinet.

What Can Be Done?

The good news? You can do something about this.

  • Ask for a med review. Bring every pill, capsule, and patch you take - including OTC ones - to your doctor or pharmacist. Ask: “Do any of these have anticholinergic effects?”
  • Ask for alternatives. For allergies? Try loratadine or cetirizine - they don’t cross into the brain. For overactive bladder? Mirabegron is a good option. For depression? SSRIs like sertraline have almost no anticholinergic effect.
  • Don’t stop cold turkey. Some meds, like antidepressants, need to be tapered slowly. Work with your doctor.
  • Use the ACB Calculator. The American Geriatrics Society launched a free app in 2024. Just type in your meds. It gives you a score and tells you which ones are risky.
Doctors need more time for this. A 2021 survey found it takes an average of 23 minutes per patient to do a full med review. But most appointments are 10 to 15 minutes. That’s why many seniors slip through the cracks.

What’s Next?

The National Institute on Aging is funding a major new study called CHIME, which will follow 3,500 older adults over four years. Half will get help reducing anticholinergic drugs. The other half won’t. The goal? Prove that lowering ACB can actually delay or prevent dementia.

Right now, experts believe anticholinergic burden contributes to 10-15% of dementia cases in older adults. That’s tens of thousands of cases every year - cases that could have been avoided.

This isn’t about scaring people away from medicine. It’s about using the right medicine. For every drug that harms the brain, there’s usually a safer alternative. The question isn’t whether you need treatment. It’s whether you need this treatment.

Frequently Asked Questions

Can anticholinergic drugs cause dementia?

They don’t cause dementia directly, but long-term use significantly increases the risk. Studies show people taking high anticholinergic burden medications for three or more years are over 50% more likely to develop dementia than those who don’t. The damage appears to accelerate brain changes already linked to Alzheimer’s.

Is Benadryl safe for seniors?

No. Diphenhydramine, the active ingredient in Benadryl, is a strong anticholinergic. It’s one of the most common causes of high anticholinergic burden in older adults. It causes confusion, memory problems, and increases dementia risk. Safer alternatives for sleep or allergies include loratadine, cetirizine, or melatonin.

How long does it take to recover from anticholinergic effects?

Improvement usually starts within 2 to 4 weeks after stopping the drug, but full recovery can take 3 to 6 months. In clinical trials, seniors saw measurable cognitive gains after 12 weeks of deprescribing. Some people never fully return to their previous level, especially if they took the drugs for years.

Are there any safe anticholinergic drugs for seniors?

There are no truly safe anticholinergics for older adults when it comes to brain health. Even mild ones add up over time. The goal isn’t to find a “safe” anticholinergic - it’s to avoid them entirely and use non-anticholinergic alternatives whenever possible.

Can I check my own anticholinergic burden?

Yes. The American Geriatrics Society released a free mobile app called the ACB Calculator in early 2024. You enter your medications, and it gives you a total score based on the latest ACB scale. A score of 3 or higher means you’re at increased risk. Talk to your doctor about what to do next.

13 Comments

  • Image placeholder

    Ashlee Montgomery

    January 9, 2026 AT 18:56

    It’s terrifying how many seniors are on these meds without knowing the risks. My grandma was on Benadryl for years for sleep. We thought her forgetfulness was just aging. Turns out, it was the pills. She improved within weeks after switching to melatonin. Why isn’t this common knowledge?

  • Image placeholder

    Paul Bear

    January 11, 2026 AT 08:33

    Let’s be precise: anticholinergic burden isn’t a ‘hidden risk’-it’s a well-documented pharmacological phenomenon with decades of peer-reviewed literature. The ACB scale, validated in multiple cohort studies including the Cache County and Health ABC trials, demonstrates a dose-response relationship with cognitive decline. The 54% increased dementia risk over three years is statistically significant (p<0.001) and remains robust after adjustment for comorbidities like depression and vascular disease. This isn’t anecdotal-it’s epidemiology.

  • Image placeholder

    lisa Bajram

    January 13, 2026 AT 04:59

    OMG I literally just talked to my 78-year-old aunt last week-she was on oxybutynin for years and thought she was ‘just getting old.’ When her pharmacist flagged it, she switched to mirabegron and now she’s remembering birthdays again!! 🙌 It’s like someone turned the lights back on. Why aren’t pharmacists doing this for EVERY senior? We need a national campaign-like ‘Don’t Let Your Pills Fog Your Mind’-with posters in pharmacies, doctor’s offices, even grocery stores. This is too important to ignore!

  • Image placeholder

    Aurora Memo

    January 14, 2026 AT 13:37

    I appreciate the depth of this post. It’s easy to blame aging, but this is a real, preventable issue. I’ve seen it in my work as a geriatric nurse. The hardest part isn’t the meds-it’s convincing families that stopping something ‘prescribed’ feels dangerous, even when it’s harming more than helping. A gentle, guided taper makes all the difference.

  • Image placeholder

    Jay Amparo

    January 15, 2026 AT 06:59

    As someone from India, I’ve seen this too. Grandparents on diphenhydramine for insomnia, or amitriptyline for ‘nerves.’ No one questions it. We don’t have the same access to pharmacists here, and doctors are overburdened. But the science is universal. Brain chemistry doesn’t care about borders. This needs global awareness.

  • Image placeholder

    Lisa Cozad

    January 16, 2026 AT 21:28

    I work in a senior center and we’ve started doing monthly med reviews with a local pharmacist. The results? People are sharper, more alert, less anxious. One man stopped his muscle relaxant and said he could finally read his grandson’s letter without rereading it five times. It’s not magic-it’s just removing the fog.

  • Image placeholder

    Ian Cheung

    January 17, 2026 AT 13:52

    Benadryl is a nightmare for seniors and no one talks about it enough. I used to take it for allergies and didn’t realize how fuzzy-headed I’d get. Imagine that every day for years. The ACB calculator is a game changer. I showed my mom how to use it. She had a score of 7. We’re working with her doctor to cut it down. Small changes, big impact.

  • Image placeholder

    Jake Nunez

    January 18, 2026 AT 08:07

    My dad was on amitriptyline for 12 years. He thought his memory lapses were normal. We switched him to sertraline. He started remembering his own birthday again. Not a joke. It’s wild how one drug can do that.

  • Image placeholder

    Christine Milne

    January 19, 2026 AT 05:59

    While I acknowledge the data presented, I must emphasize that the American Geriatrics Society’s Beers Criteria is not a binding legal standard, but a guideline developed by a subset of clinicians with potential conflicts of interest. The FDA’s warning labels are reactive, not proactive. To suggest that anticholinergic burden is the primary driver of dementia is an oversimplification that ignores genetic predisposition, socioeconomic factors, and the natural neurodegenerative trajectory of aging. This post borders on medical fearmongering.

  • Image placeholder

    Bradford Beardall

    January 20, 2026 AT 06:30

    Wait, so if I’m taking cetirizine for allergies and melatonin for sleep, I’m good? No anticholinergic risk there? What about gabapentin? I’ve heard that’s also linked to brain fog. Is that in the same category?

  • Image placeholder

    McCarthy Halverson

    January 20, 2026 AT 13:08

    Ask your pharmacist. Use the ACB app. Don’t stop cold turkey. That’s it.

  • Image placeholder

    Michael Marchio

    January 21, 2026 AT 07:38

    It’s sad, really. People don’t realize how much they’re sacrificing for convenience. Benadryl is cheap. Oxybutynin is easy. But they’re trading mental clarity for comfort-and then wonder why they can’t remember where they put their keys. It’s not the pills’ fault. It’s the mindset. We’ve normalized cognitive decline as inevitable. We’ve become lazy about health. And now we’re paying the price with our memories.

  • Image placeholder

    Jake Kelly

    January 21, 2026 AT 08:48

    Thanks for sharing this. My mom’s doctor never mentioned any of this. I’m printing out the ACB scale and taking it to her next appointment. We’ve got a lot to talk about.

Write a comment